BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20716650)

  • 1. The future of imaging: developing the tools for monitoring response to therapy in oncology: the 2009 Sir James MacKenzie Davidson Memorial lecture.
    Aboagye EO
    Br J Radiol; 2010 Oct; 83(994):814-22. PubMed ID: 20716650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bright future of radionuclides for cancer therapy.
    Nijsen JF; Krijger GC; van Het Schip AD
    Anticancer Agents Med Chem; 2007 May; 7(3):271-90. PubMed ID: 17504155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [18F]fluoromethyl-[1,2-2H4]-choline: a novel radiotracer for imaging choline metabolism in tumors by positron emission tomography.
    Leyton J; Smith G; Zhao Y; Perumal M; Nguyen QD; Robins E; Arstad E; Aboagye EO
    Cancer Res; 2009 Oct; 69(19):7721-8. PubMed ID: 19773436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving Forward in the Next Decade: Radiation Oncology Sciences for Patient-Centered Cancer Care.
    Coleman CN; Buchsbaum JC; Prasanna PGS; Capala J; Obcemea C; Espey MG; Ahmed MM; Hong JA; Vikram B
    JNCI Cancer Spectr; 2021 Aug; 5(4):. PubMed ID: 34350377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular imaging-its current role in cancer.
    McDermott S; Kilcoyne A
    QJM; 2016 May; 109(5):295-9. PubMed ID: 26253299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis Imaging in Oncology by Means of Positron Emission Tomography: A Review.
    Van de Wiele C; Ustmert S; De Spiegeleer B; De Jonghe PJ; Sathekge M; Alex M
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New PET radiopharmaceuticals beyond FDG for brain tumor imaging.
    Gulyás B; Halldin C
    Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):173-90. PubMed ID: 22617239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 18F-FES, 18F-FDG, and 18F-FMISO PET Imaging Probes for Early Prediction and Monitoring of Response to Endocrine Therapy in a Mouse Xenograft Model of ER-Positive Breast Cancer.
    He S; Wang M; Yang Z; Zhang J; Zhang Y; Luo J; Zhang Y
    PLoS One; 2016; 11(7):e0159916. PubMed ID: 27467716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The progress and promise of molecular imaging probes in oncologic drug development.
    Kelloff GJ; Krohn KA; Larson SM; Weissleder R; Mankoff DA; Hoffman JM; Link JM; Guyton KZ; Eckelman WC; Scher HI; O'Shaughnessy J; Cheson BD; Sigman CC; Tatum JL; Mills GQ; Sullivan DC; Woodcock J
    Clin Cancer Res; 2005 Nov; 11(22):7967-85. PubMed ID: 16299226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of caspase-responsive smart molecular probe for positron emission tomography imaging of drug-induced apoptosis.
    Qiu L; Wang W; Li K; Peng Y; Lv G; Liu Q; Gao F; Seimbille Y; Xie M; Lin J
    Theranostics; 2019; 9(23):6962-6975. PubMed ID: 31660080
    [No Abstract]   [Full Text] [Related]  

  • 17. The Clinical Trials Network of the Society of Nuclear Medicine.
    Graham MM
    Semin Nucl Med; 2010 Sep; 40(5):327-31. PubMed ID: 20674591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy.
    Denekamp J
    Br J Radiol; 1993 Mar; 66(783):181-96. PubMed ID: 7682469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ACR imaging network: a retrospective on 5 years of conducting multicenter trials in radiology and plans for the future.
    Hillman BJ; Gatsonis C; Schnall MD
    J Am Coll Radiol; 2004 May; 1(5):346-50. PubMed ID: 17411600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.